| Intrinsic Valuation of: CMCSA | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 4 | Market Cap | $136B | |||||
| 2021 | - | - (-) | P/E Ratio | 9 | Total Asset | $266B | |||||
| 2022 | $17B | - (-) | Net Income | $16B | Total Debt | $94B | |||||
| 2023 | $13B | -26.0% (-29.1%) | EBITDA | $38B | Total Liab | $180B | |||||
| 2024 | $13B | 2.5% (2.4%) | Opr Margin | 0.19 | Debt/Equity | 1.09 | |||||
| 2025 | $13B | -3.2% (-4.9%) | PreTax Margin | 15.49 | BV/Share | -19 | |||||
| 5Y Average FCF | $14B | -8.9% (-10.5%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.5% | Historical US Bond Yield: | 4.4% | ||||||||
| Discount Rate (WACC): | 7.4% | Current US Bond Yield: | 3.5% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (4.0%) | ||||||||||
| 2026 | $13B | MBG Intrinsic Value | $36 | ||||||||
| 2027 | $14B | ||||||||||
| 2028 | $14B | ||||||||||
| 2029 | $15B | ||||||||||
| 2030 | $15B | ||||||||||
| 2031 | $16B | ||||||||||
| Terminal Value | $330B | Net Worth/Share | $23 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $282B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $7B | $52 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $94B | WACC | 7.3% | 43 | 48 | 54 | 61 | 70 | |||
| Equity Value | $195B | 7.4% | 43 | 47 | 53 | 60 | 69 | ||||
| Shares Outstanding | 3,724,260,096 | 7.4% | 42 | 47 | 52 | 59 | 68 | ||||
| 7.9% | 37 | 41 | 45 | 51 | 57 | ||||||
| DCF Intrinsic Value | $52 | 8.4% | 33 | 36 | 40 | 44 | 49 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||